Mutation analysis of the parkin gene in Russian families with autosomal recessive juvenile parkinsonism

Mov Disord. 2003 Aug;18(8):914-9. doi: 10.1002/mds.10467.

Abstract

Autosomal recessive juvenile parkinsonism (AR-JP) is a form of hereditary parkinsonism characterized by variable clinical presentations and caused by mutations in a novel gene, parkin, on chromosome 6q25.2-27. Until now, no Russian cases of parkin-associated AR-JP have been reported on. We recruited 16 patients from 11 Russian families with dopa-responsive movement disorders according to the following criteria: 1) family history compatible with autosomal recessive inheritance; 2) onset of symptoms at </=30 years of age; and 3) the lack of mutations in the GTP cyclohydrolase I gene (in sporadic cases). Mutation screening of the parkin gene was carried out by a semiquantitative PCR assay and direct sequencing of the coding region. Six different parkin mutations (both deletions and point mutations) were identified in the index cases from four families, including a novel point mutation in the donor splice site (IVS1+1G-->A). The majority of our parkin-associated cases were characterized by early-onset dopa-responsive parkinsonism with benign course and slow progression (5 patients from two families have been followed for as long as 18-36 years), and 1 patient had a phenotype of dopa-responsive dystonia. This first description of Russian patients with AR-JP and molecularly proven parkin mutations confirms the widespread occurrence of this polymorphic hereditary extrapyramidal disorder.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antiparkinson Agents / therapeutic use
  • DNA Mutational Analysis
  • GTP Cyclohydrolase / genetics
  • Humans
  • Levodopa / therapeutic use
  • Middle Aged
  • Parkinsonian Disorders / drug therapy
  • Parkinsonian Disorders / ethnology*
  • Parkinsonian Disorders / genetics*
  • Pedigree
  • Point Mutation / genetics*
  • Severity of Illness Index
  • Ubiquitin-Protein Ligases / genetics*

Substances

  • Antiparkinson Agents
  • Levodopa
  • Ubiquitin-Protein Ligases
  • parkin protein
  • GTP Cyclohydrolase